Government Administration Activities

Janssen Pharmaceutical
Regional

FDA Approval: AKEEGA, the Game-Changing Dual Action Tablet for BRCA-Positive Metastatic Castration-Resistant Prostate Cancer Treatment

- by MyChesCo

HORSHAM, PA — The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food & Drug Administration (FDA) recently approved AKEEGA™ (niraparib and abiraterone acetate), the first-and-only dual action …

FDA Approval: AKEEGA, the Game-Changing Dual Action Tablet for BRCA-Positive Metastatic Castration-Resistant Prostate Cancer Treatment Read More

Janssen Pharmaceutical
Regional

FDA Approves TALVEY (talquetamab-tgvs), a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple Myeloma

- by MyChesCo

HORSHAM, PA — The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of TALVEY™ (talquetamab-tgvs), a first-in-class …

FDA Approves TALVEY (talquetamab-tgvs), a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple Myeloma Read More


Teleflex Incorporated
Products and Services

Teleflex Announces FDA Clearance for QuikClot Control+™ Device to Address Bleeding in Cardiac Surgical Procedures

- by MyChesCo

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced the U.S Food and Drug Administration (FDA) has cleared the QuikClot Control+™ Hemostatic Device to include mild and moderate bleeding in cardiac …

Teleflex Announces FDA Clearance for QuikClot Control+™ Device to Address Bleeding in Cardiac Surgical Procedures Read More